Lixivaptan
| CAS No. | 168079-32-1 | Cat. No. | BCP09167 |
| Name | Lixivaptan | ||
| Synonyms | VPA 985; WAY-VPA 985; VPA985; WAY VPA 985; VPA-985; | ||
| Formula | C27H21ClFN3O2 | M. Wt | 473.93 |
| Description | Arginine vasopressin (AVP) plays an important part in circulatory and water homoeostasis and is important in renal hemodynamic alterations, water retention, and cardiac remodeling in congestive heart failure (CHF). Lixivaptan is an AVP V2-receptor selective antagonist that increases water excretion and normalizes serum sodium levels. Lixivaptan has been in clinical trials for hyponatremia associated with heart failure. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Vasopressin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.